President of India applauded the country’s “biggest vaccination drive in human history with vaccines manufactured in the country itself
President of India, Droupadi Murmu unveiled the foundation stone for ICMR-National Institute of Virology (NIV), South Zone at Bengaluru in presence of Union Minister of State for Health and Family Welfare, Dr Bharti Pravin Pawar.
“I am glad to know that Indian Council of Medical Research has provided exemplary support for effective COVID management and is expanding its research infrastructure. National Institute of Virology (NIV), Pune is also taking all possible steps to increase R&D in the field of virology. It is good to know that National Institute of Virology has been designated as one of the collaborating laboratories of World Health Organization. The expansion of National Institute of Virology through Zonal Campuses across the country catering to the demands in the different geographical regions is praiseworthy”, President stated.
President of India applauded the country’s “biggest vaccination drive in human history with vaccines manufactured in the country itself. In combating the pandemic, our achievements have been better than those of many developed countries. For this feat, we are grateful to our scientists, doctors, nurses, paramedics and the staff associated with vaccination”.
Dr Pawar said, “This new NIV is a step further to strengthen our health defence system. Under Prime Minister Ayushman Bharat Health Infrastructure Mission (PM-ABHIM), funds have been approved to set up multisector national institutions and platforms including 4 Zonal National Institutes of Virology (NIVs) towards bio-security preparedness and strengthening pandemic research across the country.”
The Union Minister highlighted the role of NIV in tackling issues of public health crisis from time to time. From its inception, ICMR-NIV has led from the front in providing a rapid response to viral infections of public health importance. ICMR-NIV investigated potential antiviral drugs, undertook several kit validations, developed new diagnostics with large-scale training which contributed in making India’s first indigenous vaccine, COVAXIN. These efforts equipped the country against the initial spread of SARS CoV-2. As a result of which, today the whole world looks towards India in research and development in healthcare.”
She added that “The pandemic exposed the frailties of health systems worldwide in recognizing and responding to emerging threats to public health. In this light, South Zone ICMR-NIV laboratory in Bengaluru will be equipped with a state-of-the-art infrastructure and expertise in handling infectious agents of various risk groups. This would be crucial to continuously monitor the regional landscape of infectious diseases in the southern states of India, and thus contribute to bolstering the national surveillance of outbreak-prone infectious disease agents”.